Intellipharmaceutics International Inc. (IPCI)

[fabius]

Wim, here is mine, which is considering the very low negotiating power that Odidi has given many products are unproven:

10 generics = 5mln each = 50Mln

Regabatin = 30Mln

Rexista = 30Mln

Prodras = very difficult = 15/45Mln

technology Platform = 15Mln



Total: 140-170Mln / 43.5Mln = 3.2 - 3.9$ per share

if IPCI starts to deliver on some of important projects I would move the range in the 200-230Mln

fanta.scenario (or not ?)

most likely buyer: Purdue
most likely shares manipulator: MM on Purdue mandate
Armistice and Anson directly selling to Purdue
Odidi offered a CSO role for 10 year @ 1mln salary per year plus royalties partecipation for future commercialization